Press Release – For immediate release – 5:45PM CET –
- Median will feature its investigational imaging biomarker phenotyping system iBiopsy® and its advanced imaging analysis technology MediScan® at Booth #3203 South Hall A.
Median Technologies, The Imaging Phenomics Company®, announces today that it will be participating in the Scientific Assembly and Annual meeting of the Radiological Society of North America (RSNA), which will take place at McCormick Place, in Chicago, IL from November 26th to December 1st.
Median’s scientific and business development teams will share and showcase Median’s advanced imaging technology, featuring the iBiopsy® investigational platform and the advanced imaging analysis technology MediScan® for patient care, at Booth #3203 South Hall A.
iBiopsy®, or Imaging Biomarker Phenotyping System, is a groundbreaking imaging platform that combines non-invasive imaging biomarkers with phenomics. This unique combination of science and technology is at the core of precision medicine because it facilitates the development of novel therapies and individualized treatment strategies. iBiopsy® measures disease and treatment response without an invasive and costly biopsy.
MediScan®, recently introduced to the market, is Median’s technology portfolio for the evaluation, documentation, assessment and reporting of suspicious lesions diagnosed in CT scans.
The Annual Meeting of the Radiological Society of North America is the worldwide scientific and technical meeting of the medical imaging professional community. More than 55,000 medical imaging professionals attend each year. It has been held consecutively in Chicago since 1985.